A response to Gilbody et al : Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial : BMJ2015;351:h5627
The reaction to the Gilbody paper has been swift. Following its publication, commentaries in the Guardian, the BMJ and New Scientist all cast doubt on the effectiveness of online treatments for depression. The Australian Doctor headline reads: “GP researchers slam online CBT programs for depression”. Gilbody suggests that the previously reported positive findings from online CBT are due to the studies having been undertaken by the developers, lack of adherence and poor engagement.
However, we believe the Gilbody paper, and the subsequent media publications give the wrong impression about online CBT.
Please read more at: http://www.blackdoginstitute.org.au/newsmedia/newsdesk/index.cfm